Resistant Arterial Hypertension Cohort Study

• Status: Completed
• Trial end date: 2017-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the epidemiology of resistant hypertension, evaluate the efficacy and feasibility of a standardized drug treatment regimen (including the randomization of two doses of the diuretic used - chlorthalidone), study two interventions in the group of patients that is non-compliant, and study environmental and genetic variables of individuals with resistant hypertension in a family design.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Geneva
• Treatments: Antihypertensive Agents; Chlorthalidone

Criteria

Inclusion Criteria:

• informed consent

• resistant hypertension at the moment of inclusion

• 18 years or more, both sexes are included

• women at reproductive age: consenting to use oral contraception

Exclusion Criteria:

• patients mentally impaired or unable to give informed consent

• patients speaking only a foreign language other than French, German, or English

• patients living far away, making the study visits not practical